scholarly journals Spinal Cord Injury due to Epidural Puncture in a Patient with Spina Bifida Occulta

2006 ◽  
Vol 26 (7) ◽  
pp. 698-702 ◽  
Author(s):  
Yutaka YAMAZAKI ◽  
Atsushi SAITO ◽  
Hiromu TAKAHASHI
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Spina Bifida Occulta ◽  
Epidural Puncture ◽  
Cord Injury

Spina bifida: A congenital spinal cord injury

2013 ◽  
pp. 419-458
Author(s):  
KRISTIN J. KROSSCHELL ◽  
MARI JO PESAVENTO
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Cord Injury

scholarly journals Renal replacement treatment in patients with spina bifida or spinal cord injury.

BMJ ◽  
1989 ◽  
Vol 299 (6714) ◽  
pp. 1506-1506 ◽  
Author(s):  
G. S. Muralikrishna ◽  
R. S. Rodger ◽  
A. I. Macdougall ◽  
J. M. Boulton-Jones ◽  
M. E. Allison ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Replacement Treatment ◽  
Cord Injury

scholarly journals Pseudo-tumours of the urinary tract in patients with spinal cord injury/spina bifida

Spinal Cord ◽  
2004 ◽  
Vol 42 (5) ◽  
pp. 308-312 ◽  
Author(s):  
S Vaidyanathan ◽  
P L Hughes ◽  
P Mansour ◽  
B M Soni ◽  
Gurpreet Singh ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Urinary Tract ◽  
Spina Bifida ◽  
Cord Injury

scholarly journals Renal replacement treatment in patients with spina bifida or spinal cord injury.

BMJ ◽  
1990 ◽  
Vol 300 (6720) ◽  
pp. 331-332 ◽  
Author(s):  
J L Forsythe ◽  
M G Coulthard ◽  
R M Taylor ◽  
R E Lee
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Replacement Treatment ◽  
Cord Injury

scholarly journals The Unique Properties of Placental Mesenchymal Stromal Cells: A Novel Source of Therapy for Congenital and Acquired Spinal Cord Injury

Cells ◽  
2021 ◽  
Vol 10 (11) ◽  
pp. 2837
Author(s):  
Edwin S Kulubya ◽  
Kaitlin Clark ◽  
Dake Hao ◽  
Sabrina Lazar ◽  
Arash Ghaffari-Rafi ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Stromal Cells ◽  
Stromal Cell ◽  
Antioxidant Properties ◽  
Adult Tissue ◽  
Common Cause ◽  
Cord Injury ◽  
Fetal Repair

Spinal cord injury (SCI) is a devasting condition with no reliable treatment. Spina bifida is the most common cause of congenital SCI. Cell-based therapies using mesenchymal stem/stromal cells (MSCS) have been largely utilized in SCI. Several clinical trials for acquired SCI use adult tissue-derived MSC sources, including bone-marrow, adipose, and umbilical cord tissues. The first stem/stromal cell clinical trial for spina bifida is currently underway (NCT04652908). The trial uses early gestational placental-derived mesenchymal stem/stromal cells (PMSCs) during the fetal repair of myelomeningocele. PMSCs have been shown to exhibit unique neuroprotective, angiogenic, and antioxidant properties, all which are promising applications for SCI. This review will summarize the unique properties and current applications of PMSCs and discuss their therapeutic role for acquired SCI.

The importance of dedicated colorectal team participation in the management of spina bifida and spinal cord injury patients

2021 ◽  
Author(s):  
Jenny Stevens ◽  
Luis de La Torre ◽  
Jennifer Hall ◽  
Hope Simmons ◽  
Amy Krause ◽  
...  
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Spina Bifida ◽  
Cord Injury
Sign in / Sign up

Export Citation Format

Share Document